ArticleThe Journal of clinical investigation2016
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.
Marco Ruella et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
353 papers cite itlatest 60 shown
this paperpooled ittrialcites it